|
DE3827253A1
(de)
|
1987-08-20 |
1989-03-02 |
Sandoz Ag |
Ester und amide von cyclischen carbonsaeuren und cyclischen alkoholen und aminen sowie verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
|
|
JPH02262627A
(ja)
|
1988-12-08 |
1990-10-25 |
Japan Synthetic Rubber Co Ltd |
有機非線形光学素子
|
|
DE4014171A1
(de)
|
1990-05-03 |
1991-11-07 |
Basf Ag |
Cyanochinolinverbindungen
|
|
JPH0539272A
(ja)
|
1991-01-09 |
1993-02-19 |
Nissan Chem Ind Ltd |
ピリミジンジオン誘導体および除草剤
|
|
CA2075154A1
(en)
|
1991-08-06 |
1993-02-07 |
Neelakantan Balasubramanian |
Peptide aldehydes as antithrombotic agents
|
|
DE4126244A1
(de)
|
1991-08-08 |
1993-02-11 |
Bayer Ag |
Massefaerben von kunststoffen
|
|
GB9221383D0
(en)
|
1992-10-12 |
1992-11-25 |
Minnesota Mining & Mfg |
Photothermographic imaging materials and antifoggants therefor
|
|
US5374514A
(en)
|
1993-01-06 |
1994-12-20 |
Kirk; Mark P. |
Photothermographic materials
|
|
DK122693D0
(da)
|
1993-10-29 |
1993-10-29 |
Hempels Skibsfarve Fab J C |
Marin struktur
|
|
AUPM425294A0
(en)
|
1994-03-04 |
1994-03-31 |
Australian National University, The |
In-vitro angiogenesis assay
|
|
JPH08157461A
(ja)
|
1994-12-07 |
1996-06-18 |
Sankyo Co Ltd |
スルホン誘導体
|
|
US5576338A
(en)
|
1995-02-15 |
1996-11-19 |
Merck Frosst Canada, Inc. |
Bis (biaryl) compounds as inhibitors of leukotriene biosynthesis
|
|
US5624937A
(en)
|
1995-03-02 |
1997-04-29 |
Eli Lilly And Company |
Chemical compounds as inhibitors of amyloid beta protein production
|
|
BR9711816A
(pt)
|
1996-08-01 |
1999-08-31 |
Du Pont |
Composto, composição fungicida, método para controlar doenças de plantas causadas pelos agentes patogênicos f·ngicos de plantas, composição artropodicida e método para controlar artrópodes.
|
|
DE19638484A1
(de)
|
1996-09-20 |
1998-03-26 |
Basf Ag |
Hetaroylderivate
|
|
DE19638486A1
(de)
|
1996-09-20 |
1998-03-26 |
Basf Ag |
Hetaroylderivate
|
|
ZA986594B
(en)
|
1997-07-25 |
1999-01-27 |
Abbott Lab |
Urokinase inhibitors
|
|
US6258822B1
(en)
|
1997-08-06 |
2001-07-10 |
Abbott Laboratories |
Urokinase inhibitors
|
|
US6504031B1
(en)
|
1998-08-06 |
2003-01-07 |
Milan Bruncko |
Naphthamidine urokinase inhibitors
|
|
US6284796B1
(en)
|
1998-08-06 |
2001-09-04 |
Abbott Laboratories |
Ukokinase inhibitors
|
|
GB9819382D0
(en)
|
1998-09-04 |
1998-10-28 |
Cerebrus Ltd |
Chemical compounds I
|
|
GB9822450D0
(en)
|
1998-10-14 |
1998-12-09 |
Smithkline Beecham Plc |
Medicaments
|
|
GB9822440D0
(en)
|
1998-10-14 |
1998-12-09 |
Smithkline Beecham Plc |
Medicaments
|
|
US6927214B1
(en)
|
1999-01-15 |
2005-08-09 |
Novo Nordisk A/S |
Non-peptide GLP-1 agonists
|
|
CA2379819A1
(en)
|
1999-07-29 |
2001-02-08 |
Dana-Farber Cancer Institute, Inc. |
Inducible cancer model to study the molecular basis of host tumor cell interactions in vivo
|
|
US6893812B2
(en)
|
2000-05-30 |
2005-05-17 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Three-dimensional ex vivo angiogenesis system
|
|
US6803369B1
(en)
|
2000-07-25 |
2004-10-12 |
Smithkline Beecham Corporation |
Compounds and methods for the treatment of neoplastic disease
|
|
NZ523749A
(en)
|
2000-07-26 |
2005-03-24 |
Smithkline Beecham P |
Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
|
|
US6576644B2
(en)
|
2000-09-06 |
2003-06-10 |
Bristol-Myers Squibb Co. |
Quinoline inhibitors of cGMP phosphodiesterase
|
|
EP1719770A3
(en)
|
2000-09-21 |
2008-03-05 |
Smithkline Beecham Plc |
Quinoline derivatives as antibacterials
|
|
CN1545557A
(zh)
|
2000-11-17 |
2004-11-10 |
�ݰ�Ī�﹫˾ |
应用5,10,15,20-四(羧苯基)卟吩检测细胞及组织样本中癌前期状态的组合物和方法
|
|
GB0031086D0
(en)
|
2000-12-20 |
2001-01-31 |
Smithkline Beecham Plc |
Medicaments
|
|
GB0031088D0
(en)
|
2000-12-20 |
2001-01-31 |
Smithkline Beecham Plc |
Medicaments
|
|
GB0101577D0
(en)
|
2001-01-22 |
2001-03-07 |
Smithkline Beecham Plc |
Compounds
|
|
DE10110750A1
(de)
|
2001-03-07 |
2002-09-12 |
Bayer Ag |
Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
|
|
GB0112836D0
(en)
|
2001-05-25 |
2001-07-18 |
Smithkline Beecham Plc |
Medicaments
|
|
GB0112834D0
(en)
|
2001-05-25 |
2001-07-18 |
Smithkline Beecham Plc |
Medicaments
|
|
GB0118238D0
(en)
|
2001-07-26 |
2001-09-19 |
Smithkline Beecham Plc |
Medicaments
|
|
US20050261298A1
(en)
|
2002-01-18 |
2005-11-24 |
David Solow-Cordero |
Methods of treating conditions associated with an Edg-7 receptor
|
|
US20060111368A1
(en)
|
2002-06-26 |
2006-05-25 |
Kyowa Hakko Kogyo Co., Ltd. |
Phosphodiesterase inhibitor
|
|
GB0217294D0
(en)
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicaments
|
|
ES2340484T3
(es)
|
2002-11-05 |
2010-06-04 |
Glaxo Group Limited |
Agentes antibacterianos.
|
|
TW200507841A
(en)
|
2003-03-27 |
2005-03-01 |
Glaxo Group Ltd |
Antibacterial agents
|
|
CA2539707C
(en)
|
2003-09-23 |
2011-08-09 |
Merck & Co., Inc. |
Quinoline potassium channel inhibitors
|
|
JP2005126549A
(ja)
|
2003-10-23 |
2005-05-19 |
Konica Minolta Medical & Graphic Inc |
開始剤、組成物、ラジカル発生方法、平版印刷版作製用感光材料および平版印刷版の作製方法
|
|
PE20050676A1
(es)
|
2003-12-12 |
2005-11-02 |
Wyeth Corp |
Quinolinas referidas a enfermedades cardiovasculares
|
|
EP1773831A1
(en)
|
2004-07-08 |
2007-04-18 |
Glaxo Group Limited |
Antibacterial agents
|
|
EP1773847A2
(en)
|
2004-07-09 |
2007-04-18 |
Glaxo Group Limited |
Antibacterial agents
|
|
JP2008506695A
(ja)
|
2004-07-13 |
2008-03-06 |
グラクソ グループ リミテッド |
抗細菌剤
|
|
WO2006008644A1
(en)
|
2004-07-13 |
2006-01-26 |
Pfizer Products Inc. |
Antidiabetic compounds
|
|
UY29016A1
(es)
|
2004-07-20 |
2006-02-24 |
Boehringer Ingelheim Int |
Analogos de dipeptidos inhibidores de la hepatitis c
|
|
WO2006040522A1
(en)
|
2004-10-12 |
2006-04-20 |
Astrazeneca Ab |
Quinoline derivatives
|
|
JP2008528588A
(ja)
|
2005-01-25 |
2008-07-31 |
グラクソ グループ リミテッド |
抗菌剤
|
|
WO2006081264A1
(en)
|
2005-01-25 |
2006-08-03 |
Glaxo Group Limited |
Antibacterial agents
|
|
SG161217A1
(en)
|
2005-04-01 |
2010-05-27 |
Insa Rouen |
New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents
|
|
US7732613B2
(en)
|
2005-09-14 |
2010-06-08 |
Bristol-Myers Squibb Company |
Met kinase inhibitors
|
|
ATE444069T1
(de)
|
2005-12-20 |
2009-10-15 |
Richter Gedeon Nyrt |
Chinolin-derivate zur behandlung von mglur5- rezeptor-vermittelten erkrankungen
|
|
EP1994028A1
(en)
|
2006-03-02 |
2008-11-26 |
AstraZeneca AB |
Quinoline derivatives for treating cancer
|
|
WO2007099323A2
(en)
|
2006-03-02 |
2007-09-07 |
Astrazeneca Ab |
Quinoline derivatives
|
|
UY30183A1
(es)
|
2006-03-02 |
2007-10-31 |
Astrazeneca Ab |
Derivados de quinolina
|
|
CA2643863A1
(en)
|
2006-04-07 |
2007-10-18 |
Boehringer Ingelheim International Gmbh |
Compounds which modulate the cb2 receptor
|
|
WO2007138112A2
(en)
|
2006-06-01 |
2007-12-06 |
Devgen N.V. |
Compounds that interact with ion channels, in particular with ion channels from the kv family
|
|
WO2008010061A2
(en)
|
2006-07-17 |
2008-01-24 |
Glenmark Pharmaceuticals S.A. |
3-azabicyclo [3.1.0] hexane vanilloid receptor ligands, pharmaceutical compositions containing them, and processes for their preparation
|
|
TW200825054A
(en)
|
2006-10-18 |
2008-06-16 |
Wyeth Corp |
Quinoline compounds
|
|
AU2007325872B2
(en)
|
2006-11-08 |
2012-12-13 |
Macrogenics West, Inc. |
TES7 and antibodies that bind thereto
|
|
EP2081890B1
(en)
|
2006-11-09 |
2011-01-12 |
F. Hoffmann-La Roche AG |
Arylsulfonyl pyrrolidines as 5-ht6 inhibitors
|
|
TWI373467B
(en)
|
2007-01-11 |
2012-10-01 |
Academia Sinica |
New aniline or phenol mustrads linked to dna-affinic molecules or water-soluble aromatic rings and their use as cancer
|
|
WO2009008906A2
(en)
|
2007-02-06 |
2009-01-15 |
The Trustees Of The University Of Pennsylvania |
Therapeutic compounds for blocking dna synthesis of pox viruses
|
|
GB0704906D0
(en)
|
2007-03-14 |
2007-04-25 |
Syngenta Participations Ag |
Fungicides
|
|
EP2147310A4
(en)
|
2007-04-27 |
2010-09-08 |
Univ Rochester |
COMPOSITIONS AND METHODS OF INHIBITING G-PROTEIN SIGNALING
|
|
US7928111B2
(en)
|
2007-06-08 |
2011-04-19 |
Senomyx, Inc. |
Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
|
|
US8063220B2
(en)
|
2007-06-22 |
2011-11-22 |
Richter Gedeon Nyrt. |
Sulfonyl-quinoline derivatives
|
|
US8481572B2
(en)
*
|
2007-08-09 |
2013-07-09 |
Urifer Ltd. |
Pharmaceutical compositions and methods for the treatment of cancer
|
|
US8679836B2
(en)
|
2007-10-01 |
2014-03-25 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods of monitoring angiogenesis and metastasis in three dimensional co-cultures
|
|
WO2009082942A1
(en)
|
2007-12-19 |
2009-07-09 |
Ningbo Institute Of Materials Technology And Engineering, Chinese Academy Of Sciences |
Polythioetherimides and method for producing thereof
|
|
US8642660B2
(en)
|
2007-12-21 |
2014-02-04 |
The University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
DE102008010661A1
(de)
|
2008-02-22 |
2009-09-03 |
Dr. Felix Jäger und Dr. Stefan Drinkuth Laborgemeinschaft OHG |
Verfahren zur Herstellung von Pyridin-2-Boronsäure und Derivaten davon
|
|
JP5371118B2
(ja)
|
2008-04-30 |
2013-12-18 |
興和株式会社 |
キノリン化合物
|
|
JP5551689B2
(ja)
*
|
2008-06-17 |
2014-07-16 |
アストラゼネカ アクチボラグ |
ピリジン化合物
|
|
WO2011022216A1
(en)
|
2009-08-17 |
2011-02-24 |
High Point Pharmaceuticals, Llc |
Substituted pyridine derivatives, pharmaceutical compositions, and methods of use to treat oxidative stress
|
|
RU2595718C2
(ru)
|
2009-09-09 |
2016-08-27 |
Селджен Авиломикс Рисерч,Инк. |
Ингибиторы pi3-киназы и их применение
|
|
KR101748707B1
(ko)
|
2009-11-27 |
2017-06-20 |
삼성전자주식회사 |
ｃ-Ｍｅｔ에 특이적으로 결합하는 항체 및 그를 이용한 암 진단용 키트
|
|
CN102844304B
(zh)
|
2010-01-04 |
2014-12-31 |
日本曹达株式会社 |
含氮杂环化合物以及农园艺用杀菌剂
|
|
US20130274215A1
(en)
|
2010-04-08 |
2013-10-17 |
Fate Therapeutics, Inc. |
Pharmaceutical compositions to treat fibrosis
|
|
TWI516264B
(zh)
|
2010-05-06 |
2016-01-11 |
臺北醫學大學 |
芳香醯喹啉化合物
|
|
JP5784110B2
(ja)
|
2010-05-11 |
2015-09-24 |
サノフイ |
置換されたｎ−ヘテロアリールテトラヒドロ−イソキノリン誘導体、その製造及び治療上の使用
|
|
US8883978B2
(en)
|
2010-05-11 |
2014-11-11 |
Institute For Cancer Research |
Antibodies to tumor endothelial marker 7R
|
|
WO2011156557A2
(en)
|
2010-06-11 |
2011-12-15 |
Thomas James B |
Compounds active at the neurotensin receptor
|
|
KR101195112B1
(ko)
|
2010-06-14 |
2012-10-29 |
인하대학교 산학협력단 |
암혈관내피세포의 분리방법 및 배양방법
|
|
EP2401915A1
(en)
|
2010-06-29 |
2012-01-04 |
Basf Se |
Pyrazolopyridine compounds
|
|
EP2402338A1
(en)
|
2010-06-29 |
2012-01-04 |
Basf Se |
Pyrazolopyridine compounds
|
|
WO2012003283A1
(en)
|
2010-06-30 |
2012-01-05 |
Amgen Inc. |
Heterocyclic compounds and their use as inhibitors of pi3k activity
|
|
EP2588473A1
(en)
|
2010-06-30 |
2013-05-08 |
Amgen Inc. |
Nitrogen containing heterocyclic compounds as pik3 -delta inhibitors
|
|
CN106107406B
(zh)
|
2010-08-12 |
2020-06-09 |
弗门尼舍公司 |
提高甜味增强剂的稳定性的方法和包含稳定的甜味增强剂的组合物
|
|
RU2443697C1
(ru)
|
2010-12-21 |
2012-02-27 |
Александр Васильевич Иващенко |
Замещенные метил-амины, антагонисты серотониновых 5-ht6 рецепторов, способы получения и применения
|
|
EP2678016B1
(en)
|
2011-02-23 |
2016-08-10 |
Intellikine, LLC |
Heterocyclic compounds and uses thereof
|
|
CA2826773C
(en)
|
2011-02-24 |
2019-07-16 |
Emory University |
Jab1 blocking compositions for ossification and methods related thereto
|
|
AU2012265220A1
(en)
|
2011-05-31 |
2014-01-16 |
Merck Patent Gmbh |
Electrolyte formulations
|
|
WO2013020909A1
(en)
|
2011-08-05 |
2013-02-14 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Materials and methods for the treatment of tauopathies
|
|
ES2604958T3
(es)
|
2011-10-28 |
2017-03-10 |
Vanderbilt University |
Análogos de 2-(4-heterociclilbencil)isoindolin-1-ona sustituidos como moduladores alostéricos positivos del receptor muscarínico de acetilcolina M1
|
|
CN102516232A
(zh)
|
2011-12-14 |
2012-06-27 |
无锡美克赛医药科技有限公司 |
一种ErbB2的小分子选择性抑制剂及其应用
|
|
WO2013158928A2
(en)
|
2012-04-18 |
2013-10-24 |
Elcelyx Therapeutics, Inc. |
Chemosensory receptor ligand-based therapies
|
|
CN104583206A
(zh)
|
2012-06-15 |
2015-04-29 |
加利福尼亚大学董事会 |
用于脑癌的新颖治疗剂
|
|
CN104812389B
(zh)
|
2012-09-24 |
2020-07-17 |
润新生物公司 |
某些化学实体、组合物及方法
|
|
KR102000211B1
(ko)
|
2012-10-29 |
2019-09-30 |
삼성디스플레이 주식회사 |
유기금속 화합물 및 이를 포함한 유기 발광 소자
|
|
US20160155575A1
(en)
|
2013-07-25 |
2016-06-02 |
Basf Se |
Methine dyes with large organic counter anion for dye sensitized solar cells
|
|
EP3097093A1
(en)
|
2014-01-24 |
2016-11-30 |
Cadila Healthcare Limited |
Novel heterobicyclic compounds as kappa opioid agonists
|
|
EP3116873B1
(en)
|
2014-03-14 |
2018-02-28 |
AbbVie Deutschland GmbH & Co. KG |
Hexahydrodiazepinoquinolines carrying a cyclic radical
|
|
EP2982667A1
(en)
|
2014-08-04 |
2016-02-10 |
Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V. |
Competitive PPAR-gamma antagonists
|
|
WO2016032569A1
(en)
|
2014-08-29 |
2016-03-03 |
Celladon Corporation |
Quinolines and their use for treating endoplasmic reticulum stress-caused diseases
|
|
TWI745284B
(zh)
|
2015-01-22 |
2021-11-11 |
南韓商艾瑞多斯公司 |
化合物、彼之製法、及含彼之著色劑
|
|
US11680207B2
(en)
|
2015-03-03 |
2023-06-20 |
The Trustees Of The University Of Pennsylvania |
Direct mapping of local director field of nematic liquid crystals at the nanoscale
|
|
JP2016162983A
(ja)
|
2015-03-04 |
2016-09-05 |
ダイキン工業株式会社 |
エッチング処理用組成物及びエッチング処理方法
|
|
NZ739185A
(en)
|
2015-07-30 |
2022-10-28 |
Calgent Biotechnology Co Ltd |
Compounds and pharmaceutical composition associated with ubiquitination-proteasome system
|
|
AR106515A1
(es)
|
2015-10-29 |
2018-01-24 |
Bayer Cropscience Ag |
Sililfenoxiheterociclos trisustituidos y análogos
|
|
US10501549B2
(en)
|
2015-11-30 |
2019-12-10 |
Seoul National University R&Db Foundation |
Methods of inhibiting pathological angiogenesis with doppel-targeting molecules
|
|
MX2021006804A
(es)
|
2015-12-17 |
2023-01-13 |
Merck Patent Gmbh |
Antagonistas policiclicos del receptor 7/8 tipo toll (tlr7/8) y uso de los mismos en el tratamiento de trastornos inmunitarios.
|
|
JP6983661B2
(ja)
|
2015-12-24 |
2021-12-17 |
協和キリン株式会社 |
α、β不飽和アミド化合物
|
|
US10081668B2
(en)
|
2016-04-26 |
2018-09-25 |
Northwestern University |
Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotection
|
|
JP2019530435A
(ja)
|
2016-08-15 |
2019-10-24 |
オルガノボ インコーポレイテッド |
薬物試験のための三次元バイオプリント腫瘍モデル
|
|
TW201825465A
(zh)
|
2016-09-23 |
2018-07-16 |
美商基利科學股份有限公司 |
磷脂醯肌醇3-激酶抑制劑
|
|
TW201813963A
(zh)
|
2016-09-23 |
2018-04-16 |
美商基利科學股份有限公司 |
磷脂醯肌醇3-激酶抑制劑
|
|
WO2018068357A1
(zh)
|
2016-10-13 |
2018-04-19 |
西华大学 |
一类新型sirt2蛋白抑制剂及其在制药中的用途
|
|
WO2018119039A1
(en)
|
2016-12-23 |
2018-06-28 |
Felicitex Therapeutics, Inc. |
Derivatives of quinolines as inhibitors of dyrk1a and/or dyrk1b kinases
|
|
TW201827422A
(zh)
|
2017-01-13 |
2018-08-01 |
大陸商江蘇恆瑞醫藥股份有限公司 |
１，２，４－三嗪－３－胺類衍生物、其製備方法及其在醫藥上的應用
|
|
WO2018200592A1
(en)
|
2017-04-24 |
2018-11-01 |
Regents Of The University Of California |
Biosynthesis of bioorthogonal amino acids
|
|
US20200275656A1
(en)
|
2017-05-03 |
2020-09-03 |
Bayer Aktiengesellschaft |
Trisubstitutedsilylmethylphenoxyquinolines and analogues
|
|
WO2019037678A1
(zh)
|
2017-08-24 |
2019-02-28 |
上海迪诺医药科技有限公司 |
吡唑并[3,4-d]嘧啶-3-酮衍生物、其药物组合物及应用
|
|
WO2019173482A1
(en)
|
2018-03-06 |
2019-09-12 |
Sanford Burnham Prebys Medical Discovery Institute |
4-aminoquinoline compounds for the treatment of angiogenesis
|
|
CN115175680A
(zh)
|
2019-10-18 |
2022-10-11 |
加利福尼亚大学董事会 |
Plxdc激活剂及其用于治疗血管病症的用途
|
|
EP4045485A1
(en)
|
2019-10-18 |
2022-08-24 |
The Regents Of The University Of California |
3-phenylsulphonyl-quinoline derivatives as agents for treating pathogenic blood vessels disorders
|
|
US12590298B2
(en)
|
2019-10-18 |
2026-03-31 |
The Regents Of The University Of California |
Ex vivo tumor angiogenesis model
|
|
WO2021076903A1
(en)
|
2019-10-18 |
2021-04-22 |
The Regents Of The University Of California |
Compositions and methods for detecting plxdc1 and plxdc2 in human tissues
|